Penumbra Inc.

PEN ·Healthcare, Medical Devices, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013
Revenue $333.8M $263.3M $186.1M $125.5M $88.8M
Cost of Revenue $116.6M $92.5M $62.0M $42.7M $31.0M
Gross Profit $217.1M $170.8M $124.1M $82.8M $57.9M
Gross Margin 65.1% 64.9% 66.7% 66.0% 65.1%
Operating Expenses
Research & Development $31.7M $23.9M $18.0M $15.6M $14.1M
SG&A Expense $184.3M $148.3M $101.9M $64.3M $44.9M
Operating Income $1.2M $-1.4M $4.2M $3.0M $-1.1M
Operating Margin 0.3% -0.5% 2.2% 2.4% -1.3%
Interest Expense
Pretax Income $2.5M $-869.0K $4.0M $3.1M $-1.3M
Income Tax Expense $-3.6M $-15.7M $1.7M $894.0K $-5.4M
Net Income $4.7M $14.8M $2.4M $2.2M $4.1M
Net Margin 1.4% 5.6% 1.3% 1.8% 4.6%
EPS (Basic) $0.14 $0.49 $0.05 $-0.03 $0.04
EPS (Diluted) $0.13 $0.44 $0.04 $-0.03 $0.02
Shares Outstanding (Basic) 33.0M 30.5M 24.0M 27.7M 25.8M
Shares Outstanding (Diluted) 35.3M 33.5M 28.4M 27.7M 39.0M
Dividends Per Share
← Newer Page 2 of 2 Older →